Longevity Research

topic on 1 show · 1 statements across 1 episodes

the Y Combinator Startup Podcast

1 statements about Longevity Research, every show

Iorns: Human longevity trials are impractical without secondary biomarker endpoints
“If you do that invention, you do that intervention in humans, you're going to have to wait A really long time to know whether it actually worked, and so that clinical study is very difficult if you don't have a secondary endpoint that you can measure.”
Elizabeth Iorns Sep 13, 2017 ▶ 32:33 Elizabeth Iorns on Biotech Companies in YC · Y Combinator

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.